医药行业分析
- (2022-01-31)
- (2022-01-30)
- (2022-01-30)
- (2022-01-30)
- (2022-01-30)
- (2022-01-29)
- (2022-01-29)
- (2022-01-29)
- (2022-01-29)
- (2022-01-29)
- (2022-01-29)
- (2022-01-29)
- (2022-01-29)
- (2022-01-28)
- (2022-01-28)
- (2022-01-28)
- (2022-01-28)
- (2022-01-27)
- (2022-01-27)
- (2022-01-27)
- (2022-01-27)
- (2022-01-27)
- (2022-01-27)
- (2022-01-27)
- (2022-01-26)
- (2022-01-26)
- (2022-01-26)
- (2022-01-26)
- (2022-01-26)
- (2022-01-25)
- (2022-01-25)
- (2022-01-25)
- (2022-01-25)
- (2022-01-25)
- (2022-01-25)
- (2022-01-25)
- (2022-01-25)
- (2022-01-24)
- (2022-01-24)
- (2022-01-24)
- (2022-01-24)
- (2022-01-24)
- (2022-01-24)
- (2022-01-24)
- (2022-01-24)
- (2022-01-23)
- (2022-01-23)
HER2阳性结直肠癌(CRC)新药!阿斯利康/蔡威HER2靶向药物恩赫图:在HER2高表达的患者中 总缓解率为57.5%!
(2022-01-23)- (2022-01-22)
- (2022-01-22)
- (2022-01-22)
- (2022-01-22)
BCMAxCD3双特异性抗体!Regeneron REGN5458治疗复发/难治性多发性骨髓瘤疗效显著:总缓解率75%!
(2022-01-22)- (2022-01-22)
- (2022-01-22)
- (2022-01-22)
- (2022-01-21)
- (2022-01-21)
- (2022-01-21)
- (2022-01-21)